These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11082979)

  • 1. [The efficacy of low estrogen transdermal therapy in climacteric symptoms management].
    Gadomska H; Barcz E; Cyganek A; Marianowski L
    Ginekol Pol; 2000 Sep; 71(9):1079-82. PubMed ID: 11082979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose transdermal estrogens.
    Med Lett Drugs Ther; 2007 Aug; 49(1268):71-2. PubMed ID: 17712292
    [No Abstract]   [Full Text] [Related]  

  • 3. Low-dose transdermal estradiol for symptomatic perimenopause.
    Shulman LP; Harari D
    Menopause; 2004; 11(1):34-9. PubMed ID: 14716180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical usefulness of a low-dose maintenance therapy with transdermal estradiol gel in Japanese women with estrogen deficiency symptoms.
    Mizunuma H
    Climacteric; 2011 Oct; 14(5):581-9. PubMed ID: 21848497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approach to the patient with menopausal symptoms.
    Martin KA; Manson JE
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4567-75. PubMed ID: 19056840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Climacteric syndrome].
    Imthurn B; Maurer-Major E
    Ther Umsch; 2000 Oct; 57(10):595-9. PubMed ID: 11081369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study to look at hormonal absorption of progesterone cream used in conjunction with transdermal estrogen.
    Vashisht A; Wadsworth F; Carey A; Carey B; Studd J
    Gynecol Endocrinol; 2005 Aug; 21(2):101-5. PubMed ID: 16109596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose estrogen therapy for menopausal women: a review of efficacy and safety.
    Crandall C
    J Womens Health (Larchmt); 2003 Oct; 12(8):723-47. PubMed ID: 14588124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gradual discontinuation of hormone therapy does not prevent the reappearance of climacteric symptoms: a randomized prospective study.
    Haimov-Kochman R; Barak-Glantz E; Arbel R; Leefsma M; Brzezinski A; Milwidsky A; Hochner-Celnikier D
    Menopause; 2006; 13(3):370-6. PubMed ID: 16735933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Transdermal Estrogen Patch Use on Cardiovascular Outcomes: A Systematic Review.
    Bezwada P; Shaikh A; Misra D
    J Womens Health (Larchmt); 2017 Dec; 26(12):1319-1325. PubMed ID: 28622476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postmenopausal estrogen for treatment of hot flashes: clinical applications.
    Nelson HD
    JAMA; 2004 Apr; 291(13):1621-5. PubMed ID: 15069050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can we predict who will experience recurrent vasomotor symptoms after stopping hormone therapy?
    Gracia CR; Sondheimer S
    Menopause; 2010; 17(1):10-1. PubMed ID: 20010441
    [No Abstract]   [Full Text] [Related]  

  • 13. Hormone therapy for the management of menopause symptoms.
    Collins Fantasia H; Sutherland MA
    J Obstet Gynecol Neonatal Nurs; 2014; 43(2):226-35; quiz E18-9. PubMed ID: 24502325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helping women stop postmenopausal hormone therapy.
    Grady D
    Menopause; 2006; 13(3):323-4. PubMed ID: 16735925
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety and efficacy of low-dose esterified estrogens and methyltestosterone, alone or combined, for the treatment of hot flashes in menopausal women: a randomized, double-blind, placebo-controlled study.
    Liu J; Allgood A; Derogatis LR; Swanson S; O'Mahony M; Nedoss B; Soper H; Zbella E; Prokofieva SV; Zipfel L; Guo CY
    Fertil Steril; 2011 Jan; 95(1):366-8. PubMed ID: 20850731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What happened to WHI: menopausal hormonal therapy in 2012.
    Hansen KA; Eyster KM
    Clin Obstet Gynecol; 2012 Sep; 55(3):706-12. PubMed ID: 22828102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of raloxifene and low-dose percutaneous 17beta-estradiol on menopause symptoms and endometrium--a randomized controlled trial.
    Valiati B; Capp E; Edelweiss MI; de Freitas FM; Wender MC
    Maturitas; 2009 Jan; 62(1):81-4. PubMed ID: 19097715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of estradiol metered-dose transdermal spray in clinical practice.
    Fait T; Fialova A; Pastor Z
    Climacteric; 2018 Dec; 21(6):549-553. PubMed ID: 30296172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of the climacteric. Options abound to relieve women's midlife symptoms.
    Morrissey DR; Kirchner JT
    Postgrad Med; 2000 Jul; 108(1):85-8, 93-4, 97-100. PubMed ID: 10914121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life assessment in a chemoprevention trial: fenretinide and oral or transdermal HRT.
    Serrano D; Mariani L; Mora S; Guerrieri-Gonzaga A; Cazzaniga M; Daldoss C; Ramazzotto F; Feroce I; Decensi A; Bonanni B
    Maturitas; 2006 Aug; 55(1):69-75. PubMed ID: 16500052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.